Aspivix, the Swiss start-up behind Carevix™, an innovative device designed to transform gynecological practices, launched a crowdfunding campaign that has already raised 1.9 million euros. The initiative aims to bring together a community committed to supporting a technology focused on women’s comfort and health.
With 315 investors, the crowdfunding campaign, accessible on the Capital Cell platform, is open to all those wishing to support this major advance in women’s health. In just a few weeks, the campaign reached a funding level of € 2.6 million, exceeding the initial target of € 2.150.000. The fundraising will continue until 15 March 2025, with the aim of further industrializing the device and extending its commercialization to other markets.
